Asahi Life Asset Management’s Royalty Pharma RPRX Stock Holding History

Asahi Life Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$363K	Sell	7,566 -1,909	-20%	-$83.6K	0.23%	91
2025 Q4	$366K	Buy	+9,475	New	+$361K	0.2%	130
2024 Q4	–	Sell	-11,110	Closed	-$314K	–	214
2024 Q3	$314K	Buy	11,110 +280	+3%	+$7.76K	0.19%	146
2024 Q2	$286K	Buy	+10,830	New	+$300K	0.2%	137
2024 Q1	–	Sell	-11,650	Closed	-$327K	–	204
2023 Q4	$327K	Buy	+11,650	New	+$320K	0.18%	127

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Asahi Life Asset Management's RPRX Position: Q1 2026 in Review

Asahi Life Asset Management reduced its Royalty Pharma (RPRX) stake by 20% in Q1 2026, selling an estimated $83.6K and leaving 7,566 shares worth $363K. The position accounts for 0.23% of the portfolio, ranked #91.

Asahi Life Asset Management first reported a position in RPRX in Q4 2023 and has held it in 5 quarters since. The position peaked at $366K in Q4 2025. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

Asahi Life Asset Management held 7,566 shares of Royalty Pharma worth $363K as of Q1 2026.
Asahi Life Asset Management sold 1,909 Royalty Pharma shares in Q1 2026, an estimated $83.6K.
Royalty Pharma made up 0.23% of Asahi Life Asset Management's portfolio in Q1 2026, its #91 holding.
Asahi Life Asset Management first reported a position in Royalty Pharma in Q4 2023 and has held it in 5 quarters since.
Asahi Life Asset Management's Royalty Pharma position peaked at $366K in Q4 2025.
587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Asahi Life Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.